Sean Xu completed his D.O. at Kansas City University of Medicine and Biosciences (KCU) in 2020 after he finished his Masters’ in Medical Physiology at Case Western Reserve University. He has continuous involvement in research throughout his medical training. He contributed to a study of the neuro-inflammatory environment in spinal cord injury and association with microRNA-155 (miR-155) during his undergraduate at The Ohio State University at Dr. Popovich’s lab at the Department of Neuroscience. During his pre-clerkship training at KCU, he completed a project on a muscle-derived compound, L-aminoisobutyric acid (L-BAIBA), on restoring mitochondrial motility and morphology in ALS osteocyte cell model. Joining the Segal Lab in July 2020, he has strong interests in translational and human study and hopes to incorporate more research with his future medical career.